April 9, 2019/Neurosciences

New PRESTO Board Aims to Boost Role of Mobile Treatment in Stroke Management

Board member Shazam Hussain, MD, outlines the group’s goals

19-NEU-317-mobile-stroke-650×450

The international PRE-hospital Stroke Treatment Organization (PRESTO) is preparing to bolster its support of mobile stroke units with the formation of its first board of directors, and Cleveland Clinic stroke neurologist M. Shazam Hussain, MD, is among them.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Hussain, Director of Cleveland Clinic’s Cerebrovascular Center, was elected by the PRESTO membership in March to one of four seats on the board representing the Americas. The board of directors has a total of 13 seats — nine representing global regions that have embraced mobile stroke treatment and four representing supporting specialties, such as nursing and radiography.

“PRESTO has reached the point where we needed a more formalized structure, which is why the board has been created,” says Dr. Hussain. “It will be helpful to advancing the organization as PRESTO continues to grow and mature.”

Dr. Hussain has witnessed that growth from the start, as Cleveland Clinic was among a handful of centers that founded the international consortium. “The first two mobile stroke units were launched in Germany, and the next two were in the United States — at the University of Texas in Houston and at Cleveland Clinic,” he explains. “These four programs, along with a few other centers that had interest in mobile stroke treatment at the time, began to meet at the International Stroke Conference in the U.S. and at the European Stroke Organization Conference. At those meetings we gradually came up with the idea of starting a more organized group to support and advise on prehospital treatment, specifically mobile stroke treatment units.”

Advertisement

The result was the formation of PRESTO around the time of a May 2016 mobile stroke summit hosted by Cleveland Clinic. The organization adopted a mission of improving outcomes of patients with acute stroke worldwide by supporting research and advocacy for prehospital treatment in mobile stroke units. Its central objectives are to be a platform to enhance collaborative research and to support the proliferation of mobile stroke units through professional communication, public education and advocacy to government and industry. The rationale for PRESTO and its organizational structure were detailed in a 2017 white paper published by its founding leaders in the International Journal of Stroke (2017;12:932-940).

“PRESTO does everything from advocating to governments for appropriate reimbursement of mobile stroke treatment to helping new centers build their own mobile stroke programs to supporting research and educational initiatives,” Dr. Hussain notes. “We are seen as the experts on mobile stroke treatment, and our new board will help us make that more and more the case.”

The next PRESTO meeting will be at the 2019 European Stroke Organization Conference in Milan in May.

Advertisement

Related Articles

central vein sign on a brain MRI
CAVS-MS Advances Quest to Improve the Diagnosis of Multiple Sclerosis

New reports focus on neuroimaging biomarkers and features of atypical presentations

doctor applying force to patient's forearm to test strength
Offering Rehabilitation Care to Oncology Patients (Podcast)

New oncologic rehab program is tailored to managing the effects of cancer and its treatments

vial of blood labeled "neurofilament light chain"
Could Serum Neurofilament Light Chain Level Help Guide MS Management?

Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month

brain puzzle with piece missing and female symbol
Latest WAM Grant Recipients Take on Alzheimer’s Disease in Women Across Multiple Fronts

Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more

sleepless woman looking at clock
Sleep Apnea and Insomnia Are Highly Prevalent and Linked to Disease Worsening in Neuropsychiatric Disorders

Large cohort study suggests need for routine sleep screening as part of neurological care

neuron affected by neuromyelitis optica
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study

Early experience with the agents confirms findings from clinical trials

syringe being prepared for injection
April 15, 2024/Neurosciences/Podcast
Balancing Benefits and Pitfalls of Neurotoxin Injections (Podcast)

Determining the right dose and injecting in the right muscle can be challenging

Ad